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Abstract. During bone resorption, osteoclasts form a
tight attachment, the sealing zone, around resorption
lacunae. Vitronectin receptor has previously been
shown to be expressed in osteoclasts and it has been
suggested that it mediates the tight attachment at the
sealing zone. In this study we have shown that glycine-
arginine-glycine-aspartic acid-serine pentapeptide in-
hibits bone resorption by isolated osteoclasts and dras-
tically changes the morphology of the osteoclasts.
When the vitronectin receptor was localized by immu-
nofluorescence in rat and chicken osteoclasts cultured
on bone slices, it was found to be distributed through-
out the osteoclast cell membrane except in the sealing
zone areas. Immunoperoxidase staining of rat bone sec-
tions at the light microscopical level also revealed in-
0
TEOC1.ASTs are multinucleated cells responsible for
bone resorption . When actively resorbing they are
polarized and have three specialized cell membrane
areas. Resorption of bone takes place in the ruffled border
area, where protons and proteases are secreted into the re-
sorption lacuna between the ruffled border membrane of the
osteoclast and the bone surface (Baron et al., 1988 ; Blair et
al ., 1989; Bekker and Gay, 1990; Sundquist et al ., 1990;
Vaananen et al., 1990) . The ruffled border area is sur-
rounded by a sealing zone, which forms a tight attachment
ofthe cell membrane to the underlyingbone surface, thereby
isolating the resorption lacuna from the extracellular fluid
and permitting the maintenance of a cell-generated pH gradi-
ent. Previously we have described the formation of a specific
microfilament organization around resorption lacunae in re-
sorbing osteoclasts (Lakkakorpi et al., 1989). Recently we
have further characterized the kinetics of this microfilament
structure and demonstrated its stepwise formation into the
sealing zone area (Lakkakorpi and Vaananen, 1991). The
third specialized membrane domain of the active osteoclast,
the basolateral membrane, faces the bone marrow and is not
in contact with the mineralized bone matrix.
The molecular mechanismsby which osteoclasts attach to
the bone surface are not well understood. The vitronectin
receptor (a,a3), one member of the integrin superfamily
(Hynes, 1987), has been shown to be expressed in os-
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tense staining of the cell membrane with occasional
small unstained areas, probably corresponding to the
sealing zones. Immunoelectron microscopy confirmed
the results obtained by light microscopy showing spe-
cific labeling only at the ruffled borders and basolateral
membranes (0.82 and 2.43 gold particles/Am of mem-
brane, respectively), but not at the sealing zone areas
(0.06 gold particles/Am of membrane). Both a, and 03
subunits of the vitronectin receptor were similarly lo-
calized. These results strongly suggest that, although
the vitronectin receptor is important in the function of
osteoclasts, it is not mediating the final sealing zone
attachment of the osteoclasts to the mineralized bone
surface.
teoclasts (Davies et al., 1989; Horton, 1990; Helfrich et al .,
1992) . Bone resorption by human and chick osteoclasts can
be inhibited with antibodies against the vitronectin receptor
(Chambers et al., 1986; Horton et al., 1991) . Recently it has
been suggested that the vitronectin receptor mediates the
tight attachment of osteoclasts to bone matrix (Reinholt et
al., 1990; Sato et al., 1990), and that osteopontin is the
ligand of the osteoclast vitronectin receptor (Reinholt et al.,
1990) .
Ligand binding of 03 integrins is mediated via an argi-
nine-glycine-aspartic acid (RGD)' peptide sequence within
their ligands (Ruoslahti and Pierschbacher, 1986; Hynes,
1987; Ruoslahti and Pierschbacher, 1987). Recently Sato et
al. (1990) showed that echistatin, a protein purified from the
venom of the saw-scaled viper Echis carinatus and contain-
ing an RGD sequence, inhibits bone resorption. They also
tentatively identifiedthe echistatin receptor in osteoclasts as
the vitronectin receptor.
In this study we have examined the effects of synthetic pep-
tides with and without an RGD sequence on resorption activ-
1. Abbreviations used in this paper: anti-VNR, anti-vitronectin receptor
complex; GRGDS, glycine-arginine-glycine-aspartic acid-serine; GRGES,
glycine-arginine-glycine-glutamic acid-serine; IEM, immunoelectron mi-
croscopy; RGD, arginine-glycine-aspartic acid.ity and morphology ofosteoclasts in vitro . We have also used
several mono- and polyclonal antibodies, which recognize
different domains of vitronectin receptor, to localize this
receptor on osteoclasts at both the light and electron micro-
scopic levels .
A preliminary report of these experiments with the syn-
thetic peptides was presented at the Third International
Workshop of Cells and Cytokines in Bone and Cartilage,
Davos, Switzerland, 8-11 April 1990.
Materials andMethods
Isolation and Culture of
Osteoclastsand Determination ofthe
Resorption Activity
Procedures for the culture of ostecelasts on bone slices were slightly
modified from the original methods of Boyde et al . (1984) and Chambers
et al . (1984) and have been described previously in detail (I.akkakorpi et
al ., 1989 ; Lakkakorpi and Viiänänen, 1990) . Briefly, ostecelasts that had
been mechanically harvested fromlong bones of 3-4-d-oldrat pups or 3-6-
d-old chicks bY curetting the endosteal surface with a scalpel blade were
allowed to attach to transverse slices (100-150Wm thick) of bovine cortical
bone. After 30 min (rat) or 100 min (chicken) nonattached cells were
washed away and the cells on bone slices were cultured inDME buffered
with 20mM HEPES and containing 0.84 g/litersodiumbicarbonate, 2mM
t-glutamine, 100 IU/ml penicillin, 100 ~cg/ml streptomycin, and 109'° heat-
inactivated FCS, pH 6.9, at 37°C and 596 C02/95% air for 1 d. Studied
peptides were added to the medium after cells were allowed to attach to
bone slices .
To determine thé resorption activity, bone slices were fixed with 3
paraformaldehyde and 296 sucrose in PBS, pH 7.1, for 5 min and stained
with i% toluidine blue in 1% sodium borate . Bone slices were screened
with a 25x objective to count multinucleated ostecelasts. The cells were
then removed by ultrasonication in 0.25 M ammonium hydroxide and the
resorption pits were counted with phase contrast optics. The resorption in-
dex for each bone slice was assessed as the number of resorption pits per
osteoclast number (Sundquist et al ., 1990) . For comparison of data from
different experiments, the resorption index of control was used as 100% .
We have shown earlierthatthe multinucleated cells in these cultures are
osteoclasts since they express tartrate-resistant acid phosphatase, actively
resorb bone during the cultureperiod, and respond to calcitonin with rapid
cytoplasmic retraction and changes in microfilament organization (Lak-
kakorpi et al ., 1989 ; Lakkakorpi and Väänänen, 1990) .
Synthetic Peptides
Pentapeptide glycine-arginine-glycine-aspartic acid-serine (GRGDS) and
tripeptideRGD werepurchased from SigmaChemical Co . (St . Louis, MO) .
Pentapeptide glycine-arginine-glycine-glutamic acid-serine (GRGES) was
synthetized with an automated synthesizer (model 430A ; Applied Bio-
systems, Inc., Foster City, CA) using t-Boc chemistry and purified prepara-
tively using HPLC, and the composition was verified by amino acid se-
quencing at the Department of Biochemistry, University of Oulu (Oulu,
Finland) .
Antibodies
Several mono- and polyclonal antibodies against the vitronectin receptor,
a~ßs, were used to localize the receptor at both light and electron micro-
scopic levels. The rabbit polyclonal ântibody purchased from Telios Phar-
maceuticals, Inc . (San Diego, CA) recognizes both the a~ and ßs (and pos-
sibly ßs) subunits ofthe entire vitronectin receptor complex and was used
at 1:50 dilution (antiVNR) . Polyclonal anti-ßs and anti-a~ were a kind gift
of Dr. E . Ruoslahti (Cancer Research Center, La Jolla, CA) . The anti-ßs
antiserum was raised against a synthetic peptide encompassing the entire
cytoplasmic domain of the ßs chain and the anti-a~ antiserum against an
intracellular COOH-terminal fragment of a~ chain (Freed et al ., 1989) .
They were both used at 1:50 and 1:100 dilutions . Polyclonal RBI antibody
(Nesbitt etal ., 1989) recognizes the intracellular COON-terminal nonapep-
tide of the a  chain and was used at 1:20 dilution. Monoclonal antibodies
F4 and Fll recognize the extracellular domain of the ßs subunit (Helfrich
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et al ., 1992) and were used as tissue culture supernatants. Monoclonal anti-
body 23C6 (Horton et al ., 1985) recognizes the intact aß3 complex ofthe
vitronectin receptor and was also used as neat tissue culture supernatant .
Rhodamine-conjugated rabbit anti-mouse, rhodamine-conjugated swine
anti-rabbit, swine anti-rabbit, and rabbit anti-mouse Ig were purchased
from DAKOPATTS A/S (Glostrup, Denmark) and used at 1:50, 1:20, 1:20,
and 1:20 (for peroxidase stainings) or 1:100/1:150 (for immuncelectron mi-
croscopic [IEM]) dilutions, respectively. Rabbit and mouse peroxidase-
antiperoxidase complex were also purchased from DAKOPATTS A/S .
10-nm protein A-gold complexes were agift from Dr. Raija Sormunen (De-
partment of Pathology, University of Oulu, Oulu, Finland), and were pre-
pared according to Slot and Geuze (1985) .
Immunoperoxidase and Immunolluorescence Stainings
Paraffin sections from Carnoy fixed 17-d-old rat bone were stained by the
peroxidase-antiperoxidase technique (Sternberger, 1979) . Sections were
treated first with 1% BSA in PBS for 5 min andthen with 1096 swine serum
(for polyclonal primary antibodies) or 10% rabbit serum (for monoclonal
primary antibodies) in PBS for 60 min . Sections were then incubated with
the primary antibody overnight at 4°C, washed for 30 min in PBS, and in-
cubated with swine anti-rabbit Ig diluted 1:20 in 10% swine serum in PBS
(for polyclonal primary antibodies) or with rabbit anti-mouse Ig diluted
1:20 in 1096 rabbit serum in PBS (for monoclonal primary antibodies) for
30 min . After a 30-min wash with constant stirring in PBS, sections were
incubated with rabbit or mouse peroxidase-antiperoxidase complex diluted
1:100 in PBS for 30min. Aftera further 30-min wash in PBS the peroxidase
reaction was performed with H202 and diaminobenzidine for 5 min . Fi-
nally, sections were washed with deionized water and mounted in glycerol .
For immunofluorescense microscopy, ostecelasts cultured onbone slices
were rinsed with PBS, fixed with 3 % paraformaldehyde and 2% sucrose in
PBS for 5 min at room temperature, rinsed in PBS, permeabilized in
HepesTriton X-100 buffer (20 mM Hepes, pH 7.0, 300mM sucrose, 50
mM NaCI, 3 mM MgC12, and 0.596 Triton X-100) for 5 min at 0°C, and
finally rinsed in PBS . Bone slices were incubated with primary antibodies
for 1 h at 37°C, thoroughly rinsed in PBS, and then incubated in a
rhodamine-conjugated secondary antibody for30 min at37°C. Beforeaddi-
tion ofpolyclonal primary antibodies, bone slices were incubated with 10%
swine serum for 30 min at 37°C ; 10% swine serum was also added to the
secondary antibody solution . F-actin was stained with 5 U/ml rhodamine-
labeled phalloidin (Molecular Probes, Inc ., Eugene, OR) .
Immunoelectron Microscopy
5-d-old ratpups were killedby decapitation, the distal femurs were quickly
dissected out, and slices were cut from the primary spongiosa area under
the growth plate at 0°C . Slices were immersed in 2% fresh paraformalde-
hyde and 0.2% glutaraldehyde in 0.1 M phosphate buffer, pH 7.4, for 3 h .
Ultracryotomy was performed according to Tokuyasu (1973) with minor
modifications . Thin sections of N100 nm were prepared on a Nova
ultracryotome equipped with a diamond knife (LKB Instruments, Inc.,
Gaithersburg, MD) . Theprotein A-goldtechnique (Geuze et al ., 1991) was
used to localize the vitronectin receptor. After incubation in fluid gelatin
at 37°C, grids were washed in PBS containing 0.02 M glycine, incubated
with 1% NaBH4 for 10 min, washed in PBS, and further incubated with
Figure 1. Effects of synthetic
peptides on bone resorption
by rat osteoclasts. Each pep-
tide was tested in two to
four different experiments with
three to four different bone
slices in each concentration. ïn
control slices 102 f 33 os-
teoclasts per bone slice re-
sorbed 0.87 t 0.43 lactmae/
osteoclast in 24 h . GRGDS
caused dose-dependent inhibition of resorption with an ICS of 0.1
PM . The values for 10-'-10- ' M GRGDS differ significantly from
the control (P < 0.001) . The number of osteoclasts was significantly
smaller in the presence of 10
-s and 10-° M GRGDS (P < 0.05) and
10-°M GRGES (P < 0.01) when compared with control .
1180Figure 2 . Toluidine blue stainings showing several resorbing (a, arrows) and migrating (b, arrow) rat osteoclasts in control cultures . Re-
tracted rat osteoclasts with long extensions in the presence of 0.1 mM (c) and 1 mM (d, arrows) GRGDS peptide . Bar, 20 am.
Figure 3 Rhodamine-labeled phalloidin staining of F-actin in rat osteoclasts in control medium (a andb) and in medium containing 0.1
mM GRGDS peptide (c) . The figure shows specific ring structure of F-actin at the sealing zone area in resorbing osteoclast in a and a
typical nonresorbing osteoclast in b . Note the different cell shape and diffuse staining of F-actin in the presence ofGRGDS peptide (c) .
Bar, 20 /Am .
Lakkakotpi et al . Vitronectin Receptor in Osteoclasts
￿
118 1normal sheep serum for 30 min . The grids were then incubated with the
primary antibody diluted in PBS containing 1% sheep serum for 1 h . When
monoclonal antibody was used, grids were incubated with rabbit anti-
mouse Ig as a secondary antibody. After thorough washes with PBS, grids
were incubated with protein A-gold complexes for 1 h . Finally the grids
were washed, stained with uranyl acetate-oxalate, and embedded in 2%
methyl cellulose containing 0.3% uranyl acetate . Controls were stained
without primary antibody. More than 25 osteoclasts with each antibody
were studied under a transmission electron microscope (model 410 LS ;
Philips Electronic Instruments Co., Mahwah, NJ) .
Semiquantitation was performed afterward from pictures. The length of
unfractured cell membrane (sealing zone, ruffled border, and basolateral
membrane) was measured with an ImageMeasure program (Microscience
Inc ., Federal Way, WA) using PCVision imaging board (Imaging Technol-
ogy Inc., Woburn, MA) and the gold particles at the measured line were
counted .
Results
GRGDS pentapeptide inhibited bone resorption by isolated
rat osteoclasts in a dose-dependent manner over the range
10-3-10-a M when measured by counting the number of
resorption pits per osteoclast (Fig. 1) . At a concentration of
1 mM, total inhibition of bone resorption was achieved with
an IC50 of -0.1 jAM . The number of osteoclasts was sig-
nificantly reduced in the presence of0.1 and 1 mM GRGDS
peptide . The pentapeptide with aspartic acid replaced by
glutamic acid (GRGES) and the tripeptide, RGD, had no
significant effect on osteoclast resorption activity (Fig . 1) .
However, at a high concentration (0.1 mM) ofGRGES, the
number of osteoclasts adhering to the bone slices was sig-
nificantly reduced .
GRGDS pentapeptide concentrations of0.01mM or more
caused clearly visible changes in the shape of rat osteoclasts
(Figs . 2 and 3) . Osteoclasts were retracted from the bone
surface and had long rigid extensions . A concomitant disap-
pearance ofthe specific microfilament organization at the at-
tachment areas was revealed by actin staining (Fig . 3) .
Since the vitronectin receptor is expressed in osteoclasts,
it is possible that the interaction ofGRGDS peptide with the
vitronectin receptor caused the observed changes in os-
teoclast behavior. To localize vitronectin receptor in os-
teoclasts we used several antibodies that recognize the a, or
03 chain or the whole vitronectin receptor complex . With
peroxidase staining of rat bone sections we observed an
intense reaction at the cell membrane of osteoclasts with
occasional small unstained areas probably corresponding to
sealing zones (Fig. 4) . This staining ofosteoclast cell mem-
branes in paraffin sections was observed with antiVNR,
polyclonal anti-N3, and RBI (anti-a,.) antibodies.
Immunofluorescence staining of cultured rat and chicken
osteoclasts was performed with all the antibodies listed with
similar results . We observed specific staining all over the os-
teoclast plasma membrane ; in resorbing osteoclasts the
ruffled border areas over resorption lacunae were most inten-
sively stained . The weakest staining was found around the
resorption pits (Fig . 5) . In no case was there evidence of in-
creased accumulation of vitronectin receptor around the
edges of the resorption pits .
The results obtained at the light microscopic level sug-
gested that the vitronectin receptor in osteoclasts is not po-
larized to the sealing zone areas, and this finding was con-
firmed by IEM of rat bone sections . The IEM was carried
out with antiVNR and monoclonal Fll antibodies with simi-
lar results . Most of the immunoreaction was at the baso-
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Figure 4 . Peroxidase staining ofthe paraffin section from 17-d-old
rat bone with polyclonal anti-N3 antibody, which recognizes the
intracellular domain of the N3 chain (a), and with polyclonal RBI
antibody, which recognizes the intracellular COOH-terminal pep-
tide of the a,. chain (b) . The figure shows intense staining at the
cell membrane ofosteoclasts with occasional small unstained areas
(arrows) . Osteoclastsare attached to thebonetrabeculae (asterisks)
and surrounded by bone marrow (bm) . Several nuclei can be seen
in osteoclasts in b (arrowheads) . Bars, 40 pm (a) and 20 Fcm (b) .
lateral membrane (Fig. 6, a and d) ; the ruffled border was
also clearly stained (Fig. 6 b) . At the sealing zone we could
not find any indication ofspecific staining (Fig . 6 c) . In bone
matrix there was some nonspecific staining, but otherwise
the controls showed only minimal staining (Fig . 6 e) . The
immunoreactivity was semiquantified with the antiVNR an-
tibody (Table I) . The highest density of gold particles (2.43
gold particles/pmofmembrane) was found in the basolateral
membrane, and the ruffled border membrane and sealing
zone membrane showed only 34 and 2% of that density,
respectively. The frequency of gold particles at the sealing
zone was at the same level in anti-VNR antibody-stained and
control osteoclasts .
Discussion
In this study we describe the effects ofdifferent synthetic pep-
tides on osteoclast behavior in vitro. The pentapeptide,
GRGDS, inhibited bone resorption in a dose-dependent
1182manner with an ICso of 0.1 AM . RGD tripeptide had no
statistically significant effect on resorption activity at the
concentration tested . It has been previously reported that the
RGD tripeptide is inactive in inhibition of cell adhesion at
the doses tested ; COOH-terminal amidation of the RGD
tripeptide or addition of flanking amino acid sequences was
required for activity against integrin receptors (Piersch-
bacher and Ruoslahti, 1987) . Sato et al . (1990), using a simi-
lar resorption assay with rat osteoclasts, have recently shown
that the ICso of the tetrapeptide arginine-glycine-aspartic
acid-serine (RGDS), is 100 AM and that of echistatin, 0.1
nM . These results, when taken with our data, clearly show
that in addition to the presence of the RGD sequence, the
correct conformation at the RGD peptide region is also im-
portant for maximal inhibitory activity. Moreover, substitu-
Lakkakorpi et al . Vitronectin Receptor in Osteoclasts
Figure S . Immunofluorescence
staining of cultured rat osteo-
clasts with monoclonal F4 anti-
body, which recognizes the ex-
tracellular domain of the 03
chain (a), and with polyclonal
anti-N3 antibody, which recog-
nizes theintracellulardomain of
the 03 chain (c), and ofchicken
osteoclast with monoclonal an-
tibody 23C6, which recognizes
the a..03 vitronectin receptor
complex (d) . The figure shows
the normal light microscopic
picture of corresponding re-
sorption lacunae under the
osteoclasts (b and e) . There is
intense staining at the ruffled
border areas over resorption
pits (a, c, and d, asterisks) and
there are dark areas with very
faint staining atthe sealing zone
areas (a and d, arrows) around
the resorption pits (b and e) .
In the nonresorbing, probably
migrating, osteoclast (c, large
arrow) there is a faint stain-
ing all over the cell membrane.
Bars, 20 Am (a and b) and 10
Am (c-e) .
tion of one amino acid in the RGD sequence causes the loss
of the inhibitory effect, since pentapeptide GRGES does not
inhibit bone resorption . A similar result was obtained with
echistatin by changing the arginine to alanine in itsRGD se-
quence (Sato et al ., 1990) .
GRGDS concentrations of 0 .1 mM or more caused clear
changes in osteoclast morphology. Our data agree with the
earlier findings that higher peptide concentrations are
needed for visible morphological changes than for the inhibi-
tion of resorption (Sato et al., 1990) . Retraction of os-
teoclasts probably leads in some cases to cellular detach-
ment from bone surface, thus explaining the reduction ofthe
number of osteoclasts with high concentrations of GRGDS
peptide . The number of osteoclasts was also reduced in the
presence of 0.1 mM GRGES peptide without any specific
1183The Journal of Cell Biology, Volume 115, 1991
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1184TableI. Semiquantitation ofthe Immunoreactivity
for Vitronectin Receptor in Osteoclasts
Number of gold
Nine and five osteoclasts were measured in anti-VNR and control stainings,
respectively.
effect on resorption activity. The explanation for this phe-
nomenon is unclear, though in a separate study (Horton
et al., 1991) high doses (400 ELM) of a slightly different pep-
tide, glycine-arginine-glycine-glutamic acid-serine-proline
(GRGESP), reduced osteoclastic resorption. Similar find-
ings have been reported in other cell systems involving differ-
entintegrinreceptors. Arginine-glycine-glutamic acid (RGE)
peptides are, in fact, weak antagonists (1,000-foldless active)
when assayed in solid phase receptor assays for fibronectin
receptor (Hautanen et al ., 1989). They are generally ineffec-
tive in cell binding assays (Pierschbacher and Ruoslahti,
1987), although inhibitory activity has been reported in
some cell systems involving collagen and other integrin
receptors (Grinell et al., 1989 ; Lawrence et al., 1990).
Because of the restricted expression of al integrins in os-
teoclasts, by immunocytochemical techniques (Horton and
Davies, 1989) only evidence for expression of the RGD-
independent collagen/laminin receptor «2161 (Wayner et al.,
1988; Elices and Hemler, 1989)was found. The receptor for
the RGD-containing peptides on osteoclasts is probably the
vitronectin receptor, which does require an RGD sequence
to bind its ligand (Pytela et al ., 1985) . When we localized
the vitronectin receptor in osteoclasts with several antibod-
ies at both light and electron microscopic levels intense cell
membrane staining was observed with all the techniques
used. Semiquantitation of the immunoreactivity in IEM
showed that all specific staining was either at the basolateral
membrane or at the ruffled border (2 .43 and 0.82 gold parti-
cles/gm of membrane, respectively). The level of the stain-
ing at the sealing zone was similar in antibody-stained and
control sections (0.05 and 0.06 gold particles/Am of mem-
brane, respectively). This, together with our immunofluo-
rescence data, strongly argues against a proposed hypothesis
that the tight attachment of osteoclast sealing zone mem-
brane to bone matrix is mediated by the vitronectin receptor
(Reinholt et al., 1990). Staining with antibodies against ce,
and ,Q3 chains gave similar results, suggesting that both vi-
tronectin receptor subunits are coexpressed, and colocal-
ized, in osteoclasts. The extensive convolutions of the cell
membrane in the ruffled border intensified the staining at the
Lakkakorpi et al. Vitronectin Receptor in Osteoctasts
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light microscopic level and thus the brighter staining was
seen over resorption lacunae when the immunofluorescence
staining method was used. It is possible that ligand occu-
pancy of the vitronectin receptor might prevent the binding
ofantibodies to the extracellular domain ofthe receptor; be-
cause of this possibility we also used antibodies that recog-
nize the intracellular domain of the av and 03 subunits that
would be unaffected by ligand binding. Theseantibodies gave
results similar to the others, strengthening the suggestion that
the vitronectin receptor is lacking at the sealing zone mem-
brane. Antibody 23C6, which recognizesthe a..,Q3 vitronec-
tin receptor complex in chicken osteoclasts, also gave similar
results, indicating that the observed distribution ofvitronec-
tin receptor is not restricted to rat osteoclasts.
These data, as well as the results of others (Chambers et
al ., 1986; Horton et al., 1991), indicate that vitronectin
receptor has an important functional role in bone resorption.
However, in contrast to some earlier studies (Reinholt et al.,
1990), we could not demonstrate vitronectin receptor at the
sealing zone membrane, suggesting that tight attachment of
osteoclasts to bone surface is not mediated by this integrin .
The colocalization of vitronectin receptor and vinculin in
podosome-like structures described by Zambonin-Zallone et
al. (1989) may indicate its role in the attachment of resting
and migrating osteoclasts to bone surface. The fact that we
could not detect the vitronectin receptor at the sealing zone
membrane is in agreement with our earlier findings that the
association of actin and vinculin seen in podosomes is
clearly different in the sealing zone area (Lakkakorpi et al.,
1989; Lakkakorpi and Vaananen, 1991). Vinculin is also
lacking from the most central area of the sealing zone, indi-
cating that some organization other than a high density of
podosomes mediates the attachmentofresorbing osteoclasts
to bone surface. Thus the exact nature of the molecular
mechanism responsible for the formation oftightattachment
between the bone surface and the sealing zone membrane of
the resorbing osteoclasts remains unclear. Whether this re-
lates to the exclusion of the vitronectin receptor from the
membrane to allow close apposition of membrane to bone,
forming an ion-impermeable seal, or to the involvement of
a further class of receptors remains to be established. By
analogy with other cell types (Springer, 1990), adhesion of
osteoclasts, their migration over the bone surface, and their
formation of a tight sealing zone may be processes that are
controlled by different classes of receptors interacting with
their ligands over different distances between cell and
matrix.
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